Letters of intent vs paying customers: what Envestors actually counts

The Innovator Founder Visa application is an evidence-based assessment. The quality of market validation evidence you submit directly shapes the innovation and viability scores. Applicants often treat all evidence as equivalent — "I have letters of intent, that should cover it." Endorsing bodies do not treat them as equivalent.

Scott Horton at Envestors lists the evidence types the body accepts for the innovation pillar:

The list is ranked. The order matters. Here is how each tier carries weight, and how to stack your submission to get credit for what you actually have.

Tier 1: paying customers

The strongest possible signal. A customer who has actually transferred money to your business in exchange for the product or service eliminates almost every evidence question:

• Is there demand? Obviously yes; this customer demonstrates it.
• Will customers pay? This one did.
• Is the product delivered to a functional standard? If the customer paid and didn't demand a refund, probably yes.
• Is the pricing model viable? You have one data point on what at least one customer is willing to pay.

Even one paying customer changes the assessment materially. Two or three across different segments is a dramatically stronger position. The revenue doesn't need to be large — what matters is the transaction happened.

Evidence you'll need: invoice, receipt or payment confirmation, customer name and UK presence if relevant, description of what was delivered. Don't just assert "we have paying customers." Show them.

Tier 2: trial customers (unpaid pilots)

A customer who is actively using your product on a trial or pilot basis, even without payment, is strong evidence of genuine engagement. The signal is weaker than paid customers because the customer hasn't made a financial commitment — but the evidence of active usage compensates.

What makes a trial customer count:

• Named individual or organisation
• Active use of the actual product (not a demo)
• A definable scope (X weeks, Y users, Z tasks completed)
• Some form of contractual framing (trial agreement, letter of engagement)

A "we've spoken to 20 prospective customers who said they'd try it" is not a trial customer. It's pipeline.

Tier 3: letters of intent

Letters of intent (LoIs) rank below trial customers because they represent commitment to future action rather than current behaviour. The value of an LoI depends entirely on its specificity.

Strong LoI: Named organisation, named signatory with decision authority, specific product scope, specific price range, specific timeline for commitment decision, specific next step.

Weak LoI: Generic enthusiasm letter, no signatory authority, vague on scope and price, no timeline. These are worth little more than a LinkedIn comment.

Endorsing bodies see many LoIs. They have a sharp eye for the difference between substantive commitments and enthusiasm-theatre. An LoI that reads like it was drafted by the founder and signed by a friendly contact looks exactly like what it is.

Three ingredients make an LoI credible:

1. It was drafted (or significantly shaped) by the signatory's organisation, not the founder.
2. It specifies a decision-making process, not just an intent.
3. It identifies who at the organisation owns the budget decision.

Tier 4: patent attorney's formal opinion

For innovation-pillar evidence specifically, a formal opinion from a qualified patent attorney carries weight. Horton lists it explicitly among accepted evidence. The value:

• Independent, credentialed third-party analysis
• Specifically addresses whether the innovation is novel and defensible
• Provides language the founder didn't write themselves

What counts as a "formal opinion": a written document from a UK or internationally-recognised patent attorney, on letterhead, assessing the specific novelty claims. A generic "this looks interesting" email from a friendly patent lawyer does not count.

The cost of a formal patent attorney opinion is typically £1,500-£5,000. For applicants whose innovation pillar is marginal, this is one of the best-return spends in the whole application budget.

Tier 5: testimonials

Testimonials from industry peers, prior customers in other businesses, or advisors carry the least weight among the evidence types Horton names. They are not zero — they add colour and contextual credibility — but they don't materially move the innovation or viability scores on their own.

The exception: a testimonial from someone who has direct relevant authority (a named buyer in your target market, a named regulator, a named industry association) can carry more weight. Generic endorsement from a well-connected advisor does not.

What Innovator International says

Richard Harrison at Innovator International converges on the same logic, with different emphasis:

Harrison's bar is "engagement" — which rules out desk research and enthusiastic LoIs that don't represent real buying signals. The engagement has to come from real customers, not from your network.

See the UK market research evidence endorsing bodies accept for the companion piece on desk vs primary research, and the Envestors assessment framework for how evidence feeds into the innovation pillar.

How to stack your evidence

A strong market validation section in a submission looks approximately like this, in order of placement:

1. Paying customers section (if any) — named, with evidence
2. Trial customers section (if any) — named, with scope
3. Letters of intent from named organisations with specific commitments
4. Patent attorney opinion (if obtained) — highlighted for innovation pillar
5. Primary market research — interview counts, methodology, findings
6. Desk research — only as background, never as primary evidence
7. Testimonials from named industry figures

The presentation matters. A scanned PDF attached to the application with a generic file name signals less than a clearly titled document with explicit reference in the main application. Link the evidence tightly to the specific claim it supports.

What to do if you have weak evidence

If your evidence stack is thin, two paths are better than submitting anyway:

Delay and strengthen. Spend 3-6 months getting a trial customer or converting a strong LoI into a paid pilot. The assessment is expensive and the rejection is public within the endorsing-body network. Waiting and submitting a stronger application is almost always better than rushing a weaker one.

Reframe the evidence you have. If your strongest evidence is primary market research with 30 structured interviews, present that well. Methodology, sample, findings, and specific quotes. This isn't as strong as customer engagement, but presented rigorously it can support a passable viability case.

External context

The Home Office Innovator Founder Visa guidance requires endorsers to assess whether there is "credible" evidence of market demand. Endorsing bodies operationalise this by ranking evidence types by their inherent credibility — the ranking in this article reflects that operational practice.

Key takeaways

• Evidence is ranked, not equivalent. Paying customers beat trial customers beat letters of intent beat patent attorney opinions beat testimonials.
• One paying customer is worth a dozen enthusiastic LoIs.
• Strong LoIs name the signatory, specify scope and price, and identify the decision process.
• A formal patent attorney opinion (£1,500-£5,000) is often the best-return spend for marginal innovation-pillar cases.
• Weak evidence is better delayed than submitted; reapplication with strengthened evidence beats rejection.

• market-validation
• letters-of-intent
• customers
• envestors
• evidence